I-10 (IL-10) was originally described as that cultured synovial fluid mononuclear cells (SFMC ) cytokine synthesis inhibitory factor, because of its derived from RA patients produce IL-10 spontaneously ability to inhibit the production of IL-2, IL-3, inter- [10] . Furthermore, using antibody blocking experiferon gamma and granulocyte-macrophage colony ments, endogenously produced IL-10 was shown to stimulating factor (GM-CSF ) by Th 1 clones [1] . It is inhibit production of IL-1b, tumour necrosis factor produced by T cells, B cells, macrophages/monocytes alpha ( TNF-a) and GM-CSF by SFMC. Using an and keratinocytes, has immunoregulatory effects by in vitro model to study the effects of RA mononuclear downregulating class II major histocompatibility comcells (MNC ) on cartilage degradation, van Roon et al. plex (MHC ) expression, and inhibits the production [11] showed that IL-10 could reverse the degradation of pro-inflammatory cytokines by monocytes [2] .
induced by antigen-stimulated MNC. Moreover, IL-10 Conversely, it has stimulatory effects on B cells, includhad a stimulatory effect on proteoglycan synthesis. ing an increase in expression of MHC class II [3] and Taken together, these studies suggest an important role production of immunoglobulin, and DNA replication for IL-10 in the pathogenesis of RA. [4] . IL-10 secretion appears, therefore, to be important Felty's syndrome (FS ) is a rare complication of RA in immune regulation, contributing to the control characterized by neutropenia and often splenomegaly. of the balance between humoral and inflammatory Compared with age-matched RA patients, FS sufferers responses.
have less joint inflammation and high levels of rheumaThere are several pieces of evidence to suggest that toid factor positivity [12] . IL-10 production has not IL-10 may be important specifically in rheumatoid been measured in FS, but it can be argued that as a arthritis (RA). Although one study has shown reduced patient progresses from RA to FS, a switch from IL-10 in RA blood compared with normal individuals predominantly cell-mediated to humoral immunity [5] , another by Cush et al. [6 ] demonstrated increased occurs. Hence, IL-10 may have an important role in blood levels both by ELISA and semi-quantitative changing the disease phenotype. reverse transcriptase-polymerase chain reaction (RTThree polymorphisms within the promoter of the PCR). Both groups demonstrated elevated IL-10 levels IL-10 gene have recently been identified, their gene in RA synovial fluid. More recently, monocytes from frequencies studied in a healthy population, and their the peripheral blood of RA patients have been shown, effect on production of the cytokine by lymphocytes by RT-PCR, to produce significantly more IL-10 sponin vitro assessed [13] . One of the polymorphisms, at taneously than those from normal individuals [7] . position −1087 from the transcription start site, was Others have studied clones derived from RA synovium, associated with varying levels of cytokine production demonstrating increased production compared with after stimulation with concanavalin A (Con A). This clones from the blood [8, 9] . Lately, it has been shown was compatible with an earlier study using the luciferase assay to show that a positive regulatory region genetic predisposition to high IL-10 production might be an important contributory factor. Indeed, recent Sequence-specific oligonucleotide probing (SSOP) RA patients and controls from Manchester were work has demonstrated a high degree of heritability of IL-10 production from lymphocytes stimulated in vitro studied for all three polymorphisms by SSOP, as described [13] . For the London group, only the −1087 [15] . For this reason, we chose to study the frequencies of promoter polymorphisms in two well-characterized polymorphism was studied by this method. Two oligonucleotide probes were used to detect each allele of patient populations. the −1087 polymorphism by a dot blot technique. Ten PATIENTS AND METHODS microlitres of PCR product were blotted onto Hybond N + nylon transfer membrane (Amersham) and probes Patients were hybridized at 50°C. In Manchester, 117 RA patients were studied, all of
The probe for IL-10 1087*G ( TTCTTTGGGAG whom fulfilled the 1987 revised criteria of the American GGGGAAG) was washed stringently at 53°C, and College of Rheumatology (ACR). At Guy's, 44 that for IL-10 1087*A (ACTTCCCCTTCCCAA patients with FS were studied. These have been well AGAA) at 55°C. Probes and conditions for the −824 characterized immunogenetically for HLA class II gene and −597 polymorphisms were as previously polymorphisms, and for T-cell phenotype and clonality described [13] . [12] . All these fulfilled the ACR criteria for RA, and in addition had unexplained neutropenia of >6 months Polymorphism investigation duration. Splenomegaly was not considered an essenThere are three polymorphisms of the IL-10 protial criterion. moter which have been described previously [13] . The first at −1087 constitutes a G to A substitution, the Controls second at −824 is a C to T substitution, and the third For the Manchester controls, 119 kidney donors at −597 is a C to A substitution. The −824 substitufrom north-west England were used for frequency tion leads to the destruction of an MaeIII restriction analysis. The London controls for genotyping came site, hence the −824 C allele gives rise to fragments at from panels of DNA from normal healthy volunteers 79, 217 and 292 bp, and the −824 T allele has bands maintained in the tissue typing laboratories at Guy's at 79 and 509 bp. The −597 substitution introduces and King's College Hospitals.
an RsaI restriction site, so that the −597C allele gives rise to fragments of lengths 42, 232 and 306 bp, com-DNA extraction pared with 42, 66, 232 and 240 bp for the −597A DNA was extracted either from fresh whole blood allele. Heterozygous individuals were identified by the or from lymphocytes previously frozen in liquid nitropresence of an additional band. gen, by proteinase K digestion, phenol and chloroform extraction. DNA was then precipitated with ethanol.
Statistical analysis
Differences between control and patient allele or DNA amplification haplotype frequencies were measured by the x2 test, PCR amplification was performed on a Perkin Elmer with Yates' correction where appropriate. 9600 thermal cycler in 30 ml reaction mixtures containing test DNA, 50 m KCl, 10 m Tris-HCl, 0.1% RESULTS Triton X-100, 2.5 m MgCl 2 , 200 m each dATP, Polymorphism frequency dGTP, dTTP and dCTP (Gibco BRL), 0.5 m each Since different methods were used to study polyprimer, 0.4  betaine (Sigma) and 1 U Taq polymerase morphism between the two centres, it was important (Gibco BRL). The following cycling conditions were to ensure consistency of results. DNA samples from used: 95°C 3 min; 30 cycles of 95°C 30 s, 56°C 30 s, Manchester of known genotype were therefore ana-72°C 1 min; 72°C 3 min. Primers were used which lysed in London, and the same results obtained. Hence, amplified the segment of promoter from −1120 to there was agreement between the SSOP and RFLP −533: upstream 5∞-ATCCAAGACAACACTACTAAmethods. 3∞; downstream 5∞-TAAATATCCTCAAAGTTCC-3∞.
Figures 1a and b show typical results of genotyping for the −824 and −597 polymorphisms by RFLP. Figure 1c shows representative results of SSOP Restriction enzyme genotyping For the FS and control patients studied in London, genotyping for the −1087 polymorphism. The various alleles can clearly be distinguished. genotyping of IL-10 promoter polymorphism was modified from a previous method [13] , using restriction Allele and haplotype frequencies are summarized in Tables I and II . Allele frequencies were calculated for fragment length polymorphism (RFLP). An 8 ml aliquot of PCR product was digested overnight with 1 ml the Manchester and London control panels independently. Both were in Hardy-Weinberg equilibrium, with of MaeIII (Pharmacia Biotech) for the −824 polymorphism, or RsaI (New England Biolabs) for the identical allele frequencies. The two groups were therefore combined for statistical analysis. Three putative −597 polymorphism, and separated by size on a 2 or 3% low-melting-point agarose gel, respectively. Each haplotypes were formed: GCC, ACC and ATA for the −1087, −824 and −597 polymorphisms, respectively. gel was stained with ethidium bromide and visualized under UV light.
No significant difference in allele or haplotype frequencies was seen between controls, RA and FS DISCUSSION patients. The numbers studied allowed an 80% power This study of patients with RA and FS demonstrated to detect an odds ratio of 1.3 for RA, and an 80% no difference in the frequency of IL-10 promoter power to detect an odds ratio of 1.5 for FS, for the polymorphisms between RA and FS patients and most common haplotype.
controls. It was sufficiently powerful to ensure a low probability of missing a biologically relevant 
